FN1 and neoplasm: Through this coordinated regulation, BBR exerts sustained efficacy at distinct phases of Fn-driven CRC pathogenesis—from early-phase epithelial barrier impairment and inflammatory activation, through intermediate precancerous lesion progression, to late-stage tumor malignancy.